Enviar artigo por via de e-mail Relationship between Hedgehog Signaling Pathway and Drug Resistance of Poorly Differentiated Gliomas
- Autores: Cherepanov S.A.1,2, Grinenko N.F.2, Antonova O.M.2, Kurapov P.B.1, Shepeleva I.I.1,2, Chekhonin V.P.1,2
-
Afiliações:
- N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation
- V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
- Edição: Volume 164, Nº 3 (2018)
- Páginas: 356-361
- Seção: Article
- URL: https://ogarev-online.ru/0007-4888/article/view/239597
- DOI: https://doi.org/10.1007/s10517-018-3989-x
- ID: 239597
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
The effects of Hedgehog signaling inhibitor (cyclopamine) and activator (Shh) on drug resistance of U251-MG human glioma cells and human astrocyte culture to cisplatin, temozolomide, and doxorubicin were studied. Cyclopamine and Shh modified the drug resistance of U251-MG cells but not of human astrocytes. Experiments with cyclopamine, Shh, and chemical drugs can contribute to detection of the mechanisms of signaling effects on the drug resistance processes, while the experimental data can serve as one of the criteria for choosing individual chemotherapy for patients.
Sobre autores
S. Cherepanov
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: cherep-rsmu@yandex.ru
Rússia, Moscow; Moscow
N. Grinenko
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
Rússia, Moscow
O. Antonova
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
Rússia, Moscow
P. Kurapov
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
Rússia, Moscow
I. Shepeleva
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
Rússia, Moscow; Moscow
V. Chekhonin
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
Rússia, Moscow; Moscow
Arquivos suplementares
